This is a group of inherited eye diseases that affect the retina. The retina is the part of the eye that changes light into electrical signals. These diseases cause the retina to break down or become damaged over time, leading to vision loss.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Retinal dystrophies, also called inherited retinal diseases, are a group of genetic eye conditions in which cells in the retina slowly break down. The retina is the light-sensitive layer at the back of the eye that turns what you see into signals for the brain. As its cells stop working, vision is lost gradually, usually in both eyes. Which part of vision goes first depends on which cells are affected. In retinitis pigmentosa, the most common type, the rods (cells for seeing in dim light) fail first, so trouble seeing at night and loss of side vision come early, and the field of view can narrow to tunnel vision. In Stargardt disease and other macular dystrophies, the center of the retina is affected, so reading, recognizing faces and fine detail become hard first. Cone-rod dystrophies start with blurred central vision, light sensitivity and changes in color vision. Leber congenital amaurosis causes severe vision loss in infancy. Some types are part of a wider syndrome, such as Usher syndrome, which also affects hearing. Each type is rare, but together these conditions are a leading cause of inherited vision loss, affecting roughly 1 in 1,000 people in the United States. They are different from age-related macular degeneration and diabetic eye disease, which are not inherited in the same way.
Retinal dystrophies are caused by changes (variants) in genes that the retina needs to work and stay healthy. More than 300 genes have been linked to them, which is why the same label covers conditions that look and progress so differently. Some types appear in only one family member, while others affect several generations. The inheritance pattern matters for families. In recessive forms, both parents usually carry one changed copy of a gene without having symptoms themselves. In dominant forms, one changed copy is enough, so an affected parent can pass it on. X-linked forms, caused by genes on the X chromosome, affect males more often, and females who carry them may have milder symptoms. Even people with the same gene variant can have different severity. The condition is not caused by anything a person or parent did, and everyday habits do not cause it. Less commonly, certain medicines, infections or eye injuries can damage the retina in a way that resembles an inherited dystrophy, which is one reason a careful history is part of the diagnosis.
Diagnosis usually starts with a dilated eye exam, in which drops widen the pupils so the eye doctor can see the retina. Some types leave visible signs, such as yellowish flecks on the macula in Stargardt disease. Further tests show how the retina is working: a visual field test maps how much side vision remains, and electroretinography (ERG) records the retina's electrical response to flashes of light, which can reveal rod or cone damage before it is obvious on exam. Optical coherence tomography (OCT) and autofluorescence imaging take detailed pictures of the retina's layers and help track changes over time. Genetic testing, usually a blood or saliva test analyzing a panel of retinal genes, can identify the exact type. That can help predict how vision may change, clarify the chance of passing it on, and is required for the one approved gene therapy and for most clinical trials. A genetic cause is found in roughly 6 out of 10 people tested, so a negative or uncertain result does not rule out the diagnosis. Results are best interpreted with a genetic counselor, and a test done years ago may be worth reanalyzing as knowledge improves.
There is currently no cure for most retinal dystrophies, but care can help people make the most of their vision and keep their independence. Low vision services and vision rehabilitation are central: specialists can fit magnifiers, high-contrast and lighting strategies, screen readers and other technology, and train people to move around safely as vision changes. Sunglasses and a brimmed hat help with glare and light sensitivity outdoors, and glasses still correct ordinary focusing problems. Voretigene neparvovec (Luxturna) is a gene therapy that delivers a working copy of a retinal gene called RPE65 directly under the retina during eye surgery. It is approved only for people whose retinal dystrophy is caused by two changed copies of RPE65 and who still have enough living retinal cells, so genetic confirmation comes first. In its main trial, many treated children and adults could find their way through an obstacle course in noticeably dimmer light than before. It does not restore normal vision, it involves surgery on each eye with risks such as permanent loss of sharpness, retinal damage, infection and cataract, and it does not help other gene types. Supplements need care because advice differs by type. Vitamin A may slow vision loss in common forms of retinitis pigmentosa, but too much can harm the liver, so it should only be taken under an eye doctor's guidance. People with Stargardt disease are advised not to take supplements with more than the daily recommended amount of vitamin A. For many other types, clinical trials of gene therapies, cell therapies and new medicines offer a possible route to treatment, and a confirmed genetic diagnosis is usually needed to qualify.
Most retinal dystrophies progress slowly over years or decades, but the pace varies widely, even within one family. Some people keep useful central vision well into adulthood; others, particularly with early-onset types, have significant vision loss from childhood. Many people with retinitis pigmentosa eventually lose most side vision and some central vision. Knowing the specific gene can sometimes give a clearer picture of the likely course. Daily life often changes in stages. Night driving, dim restaurants and unfamiliar places may become difficult first, followed by reading, recognizing faces or navigating crowds, depending on the type. Side vision loss can make a person ineligible to drive under licensing rules, which can affect work and independence, so planning ahead helps. Schools and workplaces can provide accommodations, and vision rehabilitation can be revisited as needs change. Regular eye exams remain important even without a cure. People with retinitis pigmentosa are more likely to develop cataract and swelling from fluid in the center of the retina (cystoid macular edema), both of which can be treated to improve vision. Follow-up visits also track progression and keep options such as new trials in view. Living with gradual vision loss can be emotionally hard, and connecting with counselors, peer groups or patient organizations can help.
Arrange an eye exam if you or your child has trouble seeing in the dark or adjusting to dim light, bumps into things at the edges of vision, or has gradual loss of central or color vision, especially if a relative has an inherited eye disease. An infant with unusual sensitivity to light or involuntary, shaking eye movements (nystagmus) should be checked promptly, since some types cause severe vision loss in the first year of life. Contact your eye doctor if your vision changes faster than expected, central vision becomes blurred or distorted, or new glare makes daily tasks harder, since cataract or macular swelling may be treatable. New flashes of light, a sudden increase in floaters or a sudden change in vision need same-day eye care, because they can signal a retinal tear or another problem separate from the slow course of the dystrophy.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Retinal Dystrophies is like, what's helped you, or ask the community a question.